VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 124 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $153,400 | -35.5% | 10,000 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $237,900 | -53.2% | 10,000 | -50.0% | 0.00% | -62.5% |
| Q1 2023 | $508,800 | -65.2% | 20,000 | -60.0% | 0.01% | -68.0% |
| Q4 2022 | $1,460,500 | +74.5% | 50,000 | +22.6% | 0.02% | +66.7% |
| Q3 2022 | $837,000 | -10.0% | 40,787 | -49.3% | 0.02% | -6.2% |
| Q2 2022 | $930,000 | -4.7% | 80,397 | +52.3% | 0.02% | +45.5% |
| Q1 2022 | $976,000 | +19.3% | 52,774 | +27.5% | 0.01% | +37.5% |
| Q4 2021 | $818,000 | +48.5% | 41,400 | +23.6% | 0.01% | +33.3% |
| Q3 2021 | $551,000 | – | 33,508 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |